News @ at a glance

September 2006
CMAJ: Canadian Medical Association Journal;9/12/2006, Vol. 175 Issue 6, p572
Academic Journal
The article offers world news briefs related to health. A campaign to allow research institutions and pharmaceutical companies to register the 20 core elements of their clinical trials involving human beings has been launched by the World Health Organization (WHO). The "Journal of the American Medical Association" plans to tighten its financial conflict-of-interest policy beginning in January 2007. According to WHO, up to 60,000 people die annually from malignant melanomas and other forms of skin cancer.


Related Articles

  • An international standard for disclosure of clinical trial information. Godlee, Fiona // BMJ: British Medical Journal (International Edition);5/13/2006, Vol. 332 Issue 7550, p1107 

    The article comments on the efforts to create a comprehensive registration for clinical trials. Current discussions center on negotiations with the pharmaceutical and medical devices industries about the information to be registered for which trials and when it should be done. An international ...

  • Pharma Urged to Register Early Trials. Mitchell, Pete // Pharma DD: Tracking Discovery & Development;Jul/Aug2006, Vol. 1 Issue 1, p20 

    The article focuses on the proposal of the World Health Organization (WHO) concerning the publication of plans for all clinical trials by pharmaceutical companies on the Internet that include early-stage proof-of-concept studies. WHO requires all medical studies that test treatments on human...

  • WHO seeks system for tracking global clinical trials. Check, Erika // Nature;11/11/2004, Vol. 432 Issue 7014, p137 

    The article presents a report on a system for tracking global clinical trials. The World Health Organization (WHO) hopes to earn international support next week for a far-reaching plan to set up a global tracking system for clinical trials. These measures are intended to reduce the duplication...

  • Raising the standards of clinical trials and research.  // Bulletin of the World Health Organization;Sep2007, Vol. 85 Issue 9, p658 

    An interview with Sir Iain Chalmers, library editor of the James Lind Library is presented. When asked about the importance of clinical trials and how does the James Lind Library fit in, he relates that clinical trial assess whether claims about the effects of treatments are dangerous or...

  • WHO to unveil global clinical trials register. Dyer, Owen // Bulletin of the World Health Organization;Sep2004, Vol. 82 Issue 9, p714 

    Reports that the World Health Organization will unveil the first global clinical trials register in November 2004. Criticisms on drug companies that suppressed vital data; Potential of the register to establish international procedures; Plans of the WHO to use an existing numbering system.

  • Cancer's Achilles' heel.  // Marketing Health Services;Winter2007, Vol. 27 Issue 4, p9 

    The article reports that patients with advanced melanoma who participated in early tests of an experimental drug seemed to show signs of a slowdown in the spreading of the deadly skin cancer. According to Synta Pharmaceuticals Corp., test patients who received the drug survived an average of 3.7...

  • Genta 'Optimistic' Going Into Confirmatory Genasense Study. Boggs, Jennifer // BioWorld Today;8/22/2007, Vol. 18 Issue 163, p1 

    The article reports on the Phase III study of Genasense called A Randomized Controlled Trial of Genasense plus Dacarbazine Compared with Dacarbazine Alone in Patients with Advance Melanoma (AGENDA). Genta Inc. has enrolled the first patients for the trial which targets a biomarker-specific...

  • Novel Clinical Study Seeks Advanced Melanoma Patients. Kiefer, Dale // Life Extension;Apr2007, Vol. 13 Issue 4, p18 

    The article reports on the recruitment of patients for a clinical trial to investigate a new treatment for advanced melanoma in the U.S. In situ photo-immunotherapy is considered one of the most promising ways to treat advanced forms of the disease. The goal of the treatment is to stimulate...

  • Shock therapy: Electroporation from lab to clinical trials. Bryant, Rebecca // Dermatology Times;May2006, Vol. 27 Issue 5, p42 

    The article reports on the first clinical trial of electroporation on patients with metastatic melanoma. A gene therapy technique introduces genetic material which expresses the interleukin-12 protein into tumors that would trigger the immune system posed by the danger of the melanoma cells. A...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics